2m 2m 2m 2m 2m 2m 2m
MILESTONE PHARMA (MIST)
NASDAQ
$1.31+$0.03 (+2.58%)
Price as of Jun 03, 2026 7:58 PM EDT- $176.8MMarket Cap
- -21.89%1-Year Change
- BiotechnologyIndustry
MILESTONE PHARMA (MIST)
$1.31+$0.03 (+2.58%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
RTW INVESTMENTS, LP | 7.37% | 6.3M | +3.8M (+60.42%) | Mar 31, 2026 |
BLACKROCK INC. | 5.79% | 5.0M | 0 (0.00%) | Jun 30, 2024 |
RTW INVESTMENTS, LLC | 5.02% | 4.3M | 0 (0.00%) | Dec 31, 2021 |
PROPEL BIO MANAGEMENT, LLC | 4.79% | 4.1M | 0 (0.00%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 4.72% | 4.1M | -920,658 (-22.73%) | Dec 31, 2024 |
NOVO A/S | 2.95% | 2.5M | 0 (0.00%) | Dec 31, 2021 |
TWO SIGMA INVESTMENTS, LP | 2.70% | 2.3M | +802,715 (+34.64%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
Simplify Exchange Traded Funds | 1.75% | 1.5M | 0 (0.00%) | Mar 31, 2026 |
BlackRock Credit Strategies Fund | 0.27% | 231,556 | 0 (0.00%) | Mar 31, 2026 |
AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.27% | 229,128 | 0 (0.00%) | Jan 31, 2026 |
T. Rowe Price Health Sciences Fund, Inc. | 0.26% | 227,013 | 0 (0.00%) | Mar 31, 2026 |
TEKLA HEALTHCARE INVESTORS | 0.20% | 175,816 | 0 (0.00%) | Mar 31, 2026 |
T. Rowe Price New Horizons Fund, Inc. | 0.20% | 171,156 | 0 (0.00%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 0.20% | 169,500 | 0 (0.00%) | Feb 28, 2026 |
Current Ownership Distribution
- Institutions437.1M (91.70%)
- Mutual Funds22.5M (4.71%)
- Insiders17.1M (3.59%)
- Other0 (0.00%)
Insider Transactions
- 3.59% (17.1M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $4.3MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Muller Lorenz Chief Commercial Officer | Award | Feb 02, 2026 | $0.00 | 204,000 | $0.00 | 204,000 |
Bharucha David Chief Medical Officer | Award | Feb 02, 2026 | $0.00 | 204,000 | $0.00 | 204,000 |
Oliveto Joseph President and CEO | Award | Feb 02, 2026 | $0.00 | 679,000 | $0.00 | 679,000 |
Nelson Jeffrey Edward Chief Operating Officer | Award | Feb 02, 2026 | $0.00 | 204,000 | $0.00 | 204,000 |
Muller Lorenz Chief Commercial Officer | Award | Feb 02, 2026 | $0.00 | 136,000 | $0.00 | 136,000 |
Hasija Amit CFO & EVP of Corp. Development | Award | Feb 02, 2026 | $0.00 | 204,000 | $0.00 | 204,000 |
Oliveto Joseph President and CEO | Award | Feb 02, 2026 | $0.00 | 453,000 | $0.00 | 453,000 |
Nelson Jeffrey Edward Chief Operating Officer | Award | Feb 02, 2026 | $0.00 | 136,000 | $0.00 | 136,000 |
Bharucha David Chief Medical Officer | Award | Feb 02, 2026 | $0.00 | 136,000 | $0.00 | 136,000 |
Hasija Amit CFO & EVP of Corp. Development | Award | Feb 02, 2026 | $0.00 | 136,000 | $0.00 | 136,000 |
Nelson Jeffrey Edward Chief Operating Officer | Exempt | Jan 26, 2026 | $0.00 | 20,100 | $0.00 | 60,300 |
Bharucha David Chief Medical Officer | Exempt | Jan 26, 2026 | $0.00 | 20,100 | $0.00 | 60,300 |
Hasija Amit CFO & EVP of Corp. Development | Exempt | Jan 26, 2026 | $0.00 | 20,100 | $0.00 | 60,300 |
Oliveto Joseph President and CEO | Exempt | Jan 26, 2026 | $0.00 | 66,600 | $0.00 | 199,800 |
Nelson Jeffrey Edward Chief Operating Officer | Exempt | Jan 26, 2026 | $0.00 | 20,100 | $0.00 | 62,093 |
Bharucha David Chief Medical Officer | Exempt | Jan 26, 2026 | $0.00 | 20,100 | $0.00 | 125,426 |
Muller Lorenz Chief Commercial Officer | Exempt | Jan 26, 2026 | $0.00 | 20,100 | $0.00 | 60,300 |
Oliveto Joseph President and CEO | Exempt | Jan 26, 2026 | $0.00 | 66,600 | $0.00 | 517,267 |
Nelson Jeffrey Edward Chief Operating Officer | Sell | Jan 26, 2026 | $23,632.85 | 12,245 | $1.93 | 49,848 |
Bharucha David Chief Medical Officer | Sell | Jan 26, 2026 | $23,632.85 | 12,245 | $1.93 | 113,181 |
Hasija Amit CFO & EVP of Corp. Development | Exempt | Jan 26, 2026 | $0.00 | 20,100 | $0.00 | 112,093 |
Oliveto Joseph President and CEO | Sell | Jan 26, 2026 | $66,629.39 | 34,523 | $1.93 | 482,744 |
Muller Lorenz Chief Commercial Officer | Exempt | Jan 26, 2026 | $0.00 | 20,100 | $0.00 | 216,586 |
Hasija Amit CFO & EVP of Corp. Development | Sell | Jan 26, 2026 | $23,632.85 | 12,245 | $1.93 | 99,848 |
Muller Lorenz Chief Commercial Officer | Sell | Jan 26, 2026 | $21,577.40 | 11,180 | $1.93 | 205,406 |
Oliveto Joseph President and CEO | Sell | Jan 08, 2026 | $96,750.00 | 43,000 | $2.25 | 303,721 |
Oliveto Joseph President and CEO | Sell | Jan 07, 2026 | $1,125.00 | 500 | $2.25 | 346,721 |
Bharucha David Chief Medical Officer | Sell | Dec 15, 2025 | $134,576.24 | 58,007 | $2.32 | 105,326 |
Nelson Jeffrey Edward Chief Operating Officer | Sell | Dec 15, 2025 | $134,576.24 | 58,007 | $2.32 | 41,993 |
Oliveto Joseph President and CEO | Sell | Dec 15, 2025 | $308,685.28 | 133,054 | $2.32 | 450,667 |